ARKG vs KF
vs
ARKG vs KF
ARK Genomic Revolution ETF vs The Korea Fund, Inc.
vs
✓All holdings
✓Overlap Analysis
✓ETF Screener
✓Compare ETFs
Quick Verdict
KF delivered stronger 1-year returns. KF offers more diversification with 49 holdings.
Side-by-Side Comparison
| Metric | ARKG | KF |
|---|---|---|
| Fund Family | Ark Invest | The Korea Fund, Inc. (KF) |
| Expense Ratio | 0.75% | - |
| AUM | $1.3B | $332M |
| Dividend Yield | 0.00% | 1.57% |
| Holdings Count | 33 | 52 |
| Inception Date | 2014-10-31 | 1984-08-29 |
| Investment Style | Small Cap Blend | Large Cap Value |
| 1-Month Return | +21.55% | +2.16% |
| YTD Return | +44.11% | +101.75% |
| 1-Year Return | +73.03% | +191.01% |
| 3-Year Return | +7.63% | +51.14% |
| 5-Year Return | -14.46% | +18.79% |
| 10-Year Return | +10.95% | +18.23% |
| Buy Score | 90 | - |
| Momentum Score | 97 | 96 |
| Value Score | 46 | - |
Holdings Overlap
0.0%
Weight Overlap
0
Shared Holdings
81
Total Unique
Sector Allocation
Loading chart...
Frequently Asked Questions
Which has lower fees, ARKG or KF?
Expense ratio data is not currently available.
Do ARKG and KF hold the same stocks?
ARKG and KF share 0 common holdings with a 0.0% weight overlap. They hold 81 unique securities combined. The moderate overlap means holding both could provide meaningful diversification benefits.
Which performed better, ARKG or KF?
Over the past year, ARKG returned +73.03% while KF returned +191.01%. KF outperformed over this period. Past performance does not guarantee future results.